Toward an individualized determination of dialysis adequacy: a narrative review with special emphasis on incremental hemodialysis

References

• Charra B, Calemard E, Ruffet M, et al. Survival as an index of adequacy of dialysis. Kidney Int. 1992 May;41(5):1286–1291.
   PubMed Web of Science ®Google Scholar
• Mehta AN, Fenves AZ. Hemodialysis adequacy: a review. Dialysis Trans. 2010;39(1):20–22.
   Google Scholar
• Lowrie EG, Laird NM, Parker TF, et al. Effect of the hemodialysis prescription of patient morbidity: report from the national cooperative dialysis study. N Engl J Med. 1981 Nov 12;305(20):1176–1181.
   PubMed Web of Science ®Google Scholar
• Cheung AK, Rocco MV, Yan G, et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol. 2006 Feb;17(2):546–555.
   PubMed Web of Science ®Google Scholar
• Daugirdas JT. Kt/V (and especially its modifications) remains a useful measure of hemodialysis dose. Kidney Int. 2015 Sep;88(3):466–473.
   PubMed Web of Science ®Google Scholar
• Okuno S, Ishimura E, Kohno K, et al. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients. Nephrol Dial Transplant. 2009 Feb;24(2):571–577.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Kopple JD, Block G, et al. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Diseases. 2001 December 01;38(6):1251–1263.
   PubMed Web of Science ®Google Scholar
• Rhee CM, Obi Y, Mathew AT, et al. Precision medicine in the transition to dialysis and personalized renal replacement therapy. Semin Nephrol. 2018 Jul;38(4):325–335.
   PubMed Web of Science ®Google Scholar
• Cambi V, Dall’aglio P, Savazzi G, et al. Clinical assessment of haemodialysis patients with reduced small molecules removal. Proc Eur Dial Transplant Assoc. 1972;9:67–73.
   PubMedGoogle Scholar
• Cambi V, Savazzi G, Arisi L, et al. Short dialysis schedules (SDS)–finally ready to become routine? Proc Eur Dial Transplant Assoc. 1975;11:112–120.
   PubMedGoogle Scholar
• Cambi V, Arisi L, Bignardi L, et al. Preliminary results obtained with short dialysis schedules. Ateneo Parmense Acta Biomed. 1975 Sep-Oct;46(5):349–358.
   PubMedGoogle Scholar
• Agar JWM, Barraclough KA, Piccoli GB. Home haemodialysis: how it began, where it went wrong, and what it may yet be. J Nephrol. 2019 Jun;32(3):331–333.
   PubMed Web of Science ®Google Scholar
• Blagg C. What went wrong with home hemodialysis in the United States and what can be done now? Hemodial Int. 2000 Jan;4(1):55–58.
   PubMedGoogle Scholar
• Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int. 1985 Sep;28(3):526–534.
   PubMed Web of Science ®Google Scholar
• NKF-DOQI clinical practice guidelines for hemodialysis adequacy. National kidney foundation. Am J Kidney Dis. 1997 Sep;30(3 Suppl 2):S15–66.
   Google Scholar
• Owen WF Jr., Lew NL, Liu Y, et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993 Sep 30;329(14):1001–1006.
   PubMed Web of Science ®Google Scholar
• Daugirdas JT, Smye SW. Effect of a two compartment distribution on apparent urea distribution volume. Kidney Int. 1997 Apr;51(4):1270–1273.
   PubMed Web of Science ®Google Scholar
• Smye SW, Evans JH, Will E, et al. Paediatric haemodialysis: estimation of treatment efficiency in the presence of urea rebound. Clin Phys Physiol Meas. 1992 Feb;13(1):51–62.
   PubMedGoogle Scholar
• Smye SW, Dunderdale E, Brownridge G, et al. Estimation of treatment dose in high-efficiency haemodialysis. Nephron. 1994;67(1):24–29.
   PubMed Web of Science ®Google Scholar
• Daugirdas JT, Schneditz D. Overestimation of hemodialysis dose depends on dialysis efficiency by regional blood flow but not by conventional two pool urea kinetic analysis. ASAIO J. 1995 Jul-Sep;41(3):M719–24.
   PubMedGoogle Scholar
• Maduell F, Garcia-Valdecasas J, Garcia H, et al. Validation of different methods to calculate Kt/V considering postdialysis rebound. Nephrol Dial Transplant. 1997 Sep;12(9):1928–1933.
   PubMed Web of Science ®Google Scholar
• Tattersall JE, DeTakats D, Chamney P, et al. The post-hemodialysis rebound: predicting and quantifying its effect on Kt/V. Kidney Int. 1996 Dec;50(6):2094–2102.
   PubMed Web of Science ®Google Scholar
• Casino FG, Basile C, Gaudiano V, et al. A modified algorithm of the single pool urea kinetic model. Nephrol Dial Transplant. 1990;5(3):214–219.
   PubMed Web of Science ®Google Scholar
• Borah MF, Schoenfeld PY, Gotch FA, et al. Nitrogen balance during intermittent dialysis therapy of uremia. Kidney Int. 1978 Nov;14(5):491–500.
   PubMed Web of Science ®Google Scholar
• Flanigan MJ, Lim VS, Redlin J. The significance of protein intake and catabolism. Adv Ren Replace Ther. 1995 Oct;2(4):330–340.
   PubMedGoogle Scholar
• Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol. 1993Nov4;4(5):1205–1213.
   PubMed Web of Science ®Google Scholar
• Shinaberger CS, Kilpatrick RD, Regidor DL, et al. Longitudinal associations between dietary protein intake and survival in hemodialysis patients. Am J Kidney Dis. 2006 Jul;48(1):37–49.
   PubMed Web of Science ®Google Scholar
• Kim Y, Molnar MZ, Rattanasompattikul M, et al. Relative contributions of inflammation and inadequate protein intake to hypoalbuminemia in patients on maintenance hemodialysis. Int Urol Nephrol. 2013 Feb;45(1):215–227.
   PubMed Web of Science ®Google Scholar
• Uribarri J. Protein catabolic rate may underestimate dietary protein intake in hemodialysis patients. Nephron. 1999 Jun;82(2):97–99.
   PubMed Web of Science ®Google Scholar
• Ikizler TA, Burrowes JD, Byham-Gray LD, et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am J Kidney Diseases. 2020;76(3):S1–S107.
   PubMed Web of Science ®Google Scholar
• Bastani B, McNeely M, Schmitz PG. Serum bicarbonate is an independent determinant of protein catabolic rate in chronic hemodialysis. Am J Nephrol. 1996;16(5):382–385.
   PubMed Web of Science ®Google Scholar
• Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008 Feb;73(4):391–398.
   PubMed Web of Science ®Google Scholar
• Moreau-Gaudry X, Jean G, Genet L, et al. A simple protein-energy wasting score predicts survival in maintenance hemodialysis patients. J Ren Nutr. 2014 Nov;24(6):395–400.
   PubMed Web of Science ®Google Scholar
• Gupta N, Wish JB. Is it time for precision dialysis? Clin J Am Soc Nephrol. 2021 Feb 8;16(2):316–318.
   PubMed Web of Science ®Google Scholar
• Casino FG, Lopez T. The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transplant. 1996 Aug;11(8):1574–1581.
   PubMed Web of Science ®Google Scholar
• Johnson WJ, Hagge WW, Wagoner RD, et al. Effects of urea loading in patients with far-advanced renal failure. Mayo Clin Proc. 1972 Jan;47(1):21–29.
   PubMed Web of Science ®Google Scholar
• Pietrement C, Gorisse L, Jaisson S, et al. Chronic increase of urea leads to carbamylated proteins accumulation in tissues in a mouse model of CKD. PLoS One. 2013;8(12):e82506.
   PubMed Web of Science ®Google Scholar
• Park KD, Mun KC, Chang EJ, et al. Inhibition of erythropoietin activity by cyanate. Scand J Urol Nephrol. 2004;38(1):69–72.
   PubMed Web of Science ®Google Scholar
• Trecherel E, Godin C, Louandre C, et al. Upregulation of BAD, a pro-apoptotic protein of the BCL2 family, in vascular smooth muscle cells exposed to uremic conditions. Biochem Biophys Res Commun. 2012 Jan 6;417(1):479–483.
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Yuan J, Norris K. Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease. Am J Nephrol. 2013;37(1):1–6.
   PubMed Web of Science ®Google Scholar
• D’Apolito M, Du X, Zong H, et al. Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J Clin Invest. 2010 Jan;120(1):203–213.
   PubMed Web of Science ®Google Scholar
• Lau WL, Vaziri ND. Urea, a true uremic toxin: the empire strikes back. Clin Sci (Lond). 2017Jan1;131(1):3–12.
   PubMed Web of Science ®Google Scholar
• Meyer TW, Sirich TL, Hostetter TH. Dialysis cannot be dosed. Semin Dial. 2011 Sep-Oct;24(5):471–479.
   PubMed Web of Science ®Google Scholar
• Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002 Dec 19;347(25):2010–2019.
   PubMed Web of Science ®Google Scholar
• Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002 May;13(5):1307–1320.
   PubMed Web of Science ®Google Scholar
• Depner T, Daugirdas J, Greene T, et al. Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int. 2004 Apr;65(4):1386–1394.
   PubMed Web of Science ®Google Scholar
• Greene T, Daugirdas J, Depner T, et al. Association of achieved dialysis dose with mortality in the hemodialysis study: an example of “dose-targeting bias.” J Am Soc Nephrol. 2005 Nov;16(11):3371–3380.
   PubMed Web of Science ®Google Scholar
• Lowrie EG, Li Z, Ofsthun N, et al. Body size, dialysis dose and death risk relationships among hemodialysis patients. Kidney Int. 2002 Nov;62(5):1891–1897.
   PubMed Web of Science ®Google Scholar
• Spalding EM, Chandna SM, Davenport A, et al. Kt/V underestimates the hemodialysis dose in women and small men. Kidney Int. 2008 Aug;74(3):348–355.
   PubMed Web of Science ®Google Scholar
• Ramirez SP, Kapke A, Port FK, et al. Dialysis dose scaled to body surface area and size-adjusted, sex-specific patient mortality. Clin J Am Soc Nephrol. 2012 Dec;7(12):1977–1987.
   PubMed Web of Science ®Google Scholar
• Sarkar SR, Kotanko P, Heymsfeld SB, et al. Quest for V: body composition could determine dialysis dose. Semin Dial. 2007 Sep-Oct;20(5):379–382.
   PubMed Web of Science ®Google Scholar
• Manini TM. Energy expenditure and aging. Ageing Res Rev. 2010 Jan;9(1):1–11.
   PubMed Web of Science ®Google Scholar
• Tattersall J, Farrington K, Gentile G, et al. Is Kt/V useful in elderly dialysis patients? Pro and con arguments. Nephrol Dial Transplant. 2018 May 1;33(5):742–750.
   PubMed Web of Science ®Google Scholar
• Maduell F, Ramos R, Palomares I, et al. Impact of targeting Kt instead of Kt/V. Nephrol Dial Transplant. 2013 Oct;28(10):2595–2603.
   PubMed Web of Science ®Google Scholar
• Wabel P, Moissl U, Chamney P, et al. Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant. 2008 Sep;23(9):2965–2971.
   PubMed Web of Science ®Google Scholar
• Morgenstern BZ, Wuhl E, Nair KS, et al. Anthropometric prediction of total body water in children who are on pediatric peritoneal dialysis. J Am Soc Nephrol. 2006 Jan;17(1):285–293.
   PubMed Web of Science ®Google Scholar
• Mendley SR, Majkowski NL, Schoeller DA. Validation of estimates of total body water in pediatric dialysis patients by deuterium dilution. Kidney Int. 2005 May;67(5):2056–2062.
   PubMed Web of Science ®Google Scholar
• Das SK. Body composition measurement in severe obesity. Curr Opin Clin Nutr Metab Care. 2005 Nov;8(6):602–606.
   PubMed Web of Science ®Google Scholar
• Morton AR, Singer MA. The problem with Kt/V: dialysis dose should be normalized to metabolic rate not volume. Semin Dial. 2007 Jan-Feb;20(1):12–15.
   PubMed Web of Science ®Google Scholar
• Lowrie EG, Li Z, Ofsthun N, et al. The online measurement of hemodialysis dose (Kt): clinical outcome as a function of body surface area. Kidney Int. 2005 Sep;68(3):1344–1354.
   PubMed Web of Science ®Google Scholar
• Daugirdas JT, Levin NW, Kotanko P, et al. Comparison of proposed alternative methods for rescaling dialysis dose: resting energy expenditure, high metabolic rate organ mass, liver size, and body surface area. Semin Dial. 2008 Sep-Oct;21(5):377–384.
   PubMed Web of Science ®Google Scholar
• Lowrie EG, Chertow GM, Lew NL, et al. The urea [clearance x dialysis time] product (Kt) as an outcome-based measure of hemodialysis dose. Kidney Int. 1999 Aug;56(2):729–737.
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis. 2015; 66 (5):884–930.
   PubMed Web of Science ®Google Scholar
• Saran R, Bragg-Gresham JL, Levin NW, et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int. 2006 Apr;69(7):1222–1228.
   PubMed Web of Science ®Google Scholar
• Rocco MV, Lockridge RS Jr., Beck GJ, et al. The effects of frequent nocturnal home hemodialysis: the frequent hemodialysis network nocturnal trial. Kidney Int. 2011 Nov;80(10):1080–1091.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Unruh M, Zager PG, et al. Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy. Am J Kidney Dis. 2014 Aug;64(2):181–186.
   PubMed Web of Science ®Google Scholar
• Wong J, Vilar E, Davenport A, et al. Incremental haemodialysis. Nephrol Dial Transplant. 2015 Oct;30(10):1639–1648.
   PubMed Web of Science ®Google Scholar
• Basile C, Casino FG, Kalantar-Zadeh K. Is incremental hemodialysis ready to return on the scene? From empiricism to kinetic modelling. J Nephrol. 2017 Aug;30(4):521–529.
   PubMed Web of Science ®Google Scholar
• Termorshuizen F, Dekker FW, van Manen JG, et al. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol. 2004 Apr;15(4):1061–1070.
   PubMed Web of Science ®Google Scholar
• Obi Y, Rhee CM, Mathew AT, et al. Residual kidney function decline and mortality in incident hemodialysis patients. J Am Soc Nephrol. 2016 Dec;27(12):3758–3768.
   PubMed Web of Science ®Google Scholar
• Mathew AT, Fishbane S, Obi Y, et al. Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney Int. 2016 Aug;90(2):262–271.
   PubMed Web of Science ®Google Scholar
• Eloot S, Van Biesen W, Glorieux G, et al. Does the adequacy parameter Kt/V(urea) reflect uremic toxin concentrations in hemodialysis patients? PLoS One. 2013;8(11):e76838.
   PubMed Web of Science ®Google Scholar
• Parker TF 3rd, Husni L, Huang W, et al. Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis. 1994 May;23(5):670–680.
   PubMed Web of Science ®Google Scholar
• Vanholder R, Argiles A, Jankowski J, et al. A history of uremic toxicity and of the European Uremic Toxin work group (EUTox). Clin Kidney J. 2021. https://doi.org/10.1093/ckj/sfab011.
   Google Scholar
• Vanholder R, De Smet R, Glorieux G, et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 2003 May;63(5):1934–1943.
   PubMed Web of Science ®Google Scholar
• Wolley MJ, Hutchison CA. Large uremic toxins: an unsolved problem in end-stage kidney disease. Nephrol Dial Transplant. 2018 Oct 1;33(suppl_3):iii6–iii11.
   PubMedGoogle Scholar
• Wu P-H, Lin Y-T, Chiu Y-W, et al. The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients. Sci Rep. 2021 February 15;11(1):3786.
   PubMed Web of Science ®Google Scholar
• Duranton F, Cohen G, De Smet R, et al. Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol. 2012 Jul;23(7):1258–1270.
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2017;2017(7):1–59.
   Google Scholar
• Fukagawa M, Yokoyama K, Koiwa F, et al. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial. 2013 Jun;17(3):247–288.
   PubMed Web of Science ®Google Scholar
• Duque EJ, Elias RM, Moysés RMA. Parathyroid Hormone: a Uremic Toxin. Toxins (Basel). 2020;12(3):189.
   Web of Science ®Google Scholar
• Zhan Z, Smyth B, Toussaint ND, et al. Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study. BMC Nephrol. 2019 Jul 12;20(1):258.
   PubMedGoogle Scholar
• Ferraresi M, Pia A, Guzzo G, et al. Calcium-phosphate and parathyroid intradialytic profiles: a potential aid for tailoring the dialysate calcium content of patients on different hemodialysis schedules. Hemodialysis Int. 2015;19(4):572–582.
   PubMed Web of Science ®Google Scholar
• Masakane I, Sakurai K. Current approaches to middle molecule removal: room for innovation. Nephrol Dial Transplant. 2018Oct1;33(suppl_3):iii12–iii21.
   PubMedGoogle Scholar
• Gejyo F, Yamada T, Odani S, et al. A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun. 1985 Jun 28;129(3):701–706.
   PubMed Web of Science ®Google Scholar
• European Best Practice Guidelines Expert Group on Hemodialysis ERA. II.2 Haemodialysis dose quantification: middle molecules (MM). Nephrol Dialysis Transplantation. 2002;17(suppl_7):21–23.
   Google Scholar
• Roumelioti ME, Trietley G, Nolin TD, et al. Beta-2 microglobulin clearance in high-flux dialysis and convective dialysis modalities: a meta-analysis of published studies. Nephrol Dial Transplant. 2018 Jun 1;33(6):1025–1039.
   PubMed Web of Science ®Google Scholar
• Eloot S, Van Biesen W, Dhondt A, et al. Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int. 2008 Mar;73(6):765–770.
   PubMed Web of Science ®Google Scholar
• Santoro A, Mancini E, Bolzani R, et al. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial. Am J Kidney Dis. 2008 Sep;52(3):507–518.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Martin-Malo A, Hannedouche T, et al. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol. 2009 Mar;20(3):645–654.
   PubMed Web of Science ®Google Scholar
• Asci G, Tz H, Ozkahya M, et al. The impact of membrane permeability and dialysate purity on cardiovascular outcomes. J Am Soc Nephrol. 2013 May;24(6):1014–1023.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Martin-Malo A, Hannedouche T, et al. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol. 2009 Mar;20(3):645–654.
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Kawanishi H, Suzuki K, et al. Japanese society for dialysis therapy clinical guideline for “Maintenance hemodialysis: hemodialysis prescriptions.” Ther Apher Dial. 2015 Mar;19(Suppl 1):67–92.
   PubMedGoogle Scholar
• Haroon S, Davenport A. Choosing a dialyzer: what clinicians need to know. Hemodial Int. 2018 Oct;22(S2):S65–S74.
   PubMedGoogle Scholar
• Jaques DA, Davenport A. Serum beta2-microglobulin as a predictor of residual kidney function in peritoneal dialysis patients. J Nephrol. 2021 Apr;34(2):473–481.
   PubMed Web of Science ®Google Scholar
• Kirsch AH, Lyko R, Nilsson LG, et al. Performance of hemodialysis with novel medium cut-off dialyzers. Nephrol Dial Transplant. 2017 Jan 1;32(1):165–172.
   PubMed Web of Science ®Google Scholar
• Oshihara W, Nagao H, Megano H, et al. Trial use of a polymethylmethacrylate membrane for the removal of free immunoglobulin light chains in dialysis patients. NDT Plus. 2010 May;3(Suppl 1):i3–i7.
   PubMedGoogle Scholar
• Hutchison CA, Cockwell P, Reid S, et al. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in Vitro and In Vivo studies. J Am Soc Nephrol. 2007;18(3):886–895.
   PubMed Web of Science ®Google Scholar
• Vanholder R, Schepers E, Pletinck A, et al. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J Am Soc Nephrol. 2014 Sep;25(9):1897–1907.
   PubMed Web of Science ®Google Scholar
• Sirich TL, Luo FJ, Plummer NS, et al. Selectively increasing the clearance of protein-bound uremic solutes. Nephrol Dial Transplant. 2012 Apr;27(4):1574–1579.
   PubMed Web of Science ®Google Scholar
• Rysz J, Franczyk B, Lawinski J, et al. The Impact of CKD on uremic toxins and gut microbiota. Toxins (Basel). 2021 Mar 31;13:4.
   Web of Science ®Google Scholar
• Poesen R, Windey K, Neven E, et al. The Influence of CKD on colonic microbial metabolism. J Am Soc Nephrol. 2016 May;27(5):1389–1399.
   PubMed Web of Science ®Google Scholar
• Wang X, Yang S, Li S, et al. Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. Gut. 2020 Dec;69(12):2131–2142.
   PubMed Web of Science ®Google Scholar
• Wong J, Piceno YM, DeSantis TZ, et al. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol. 2014;39(3):230–237.
   PubMed Web of Science ®Google Scholar
• Yang T, Richards EM, Pepine CJ, et al. The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease. Nat Rev Nephrol. 2018 Jul;14(7):442–456.
   PubMed Web of Science ®Google Scholar
• Koppe L, Pillon NJ, Vella RE, et al. p-Cresyl sulfate promotes insulin resistance associated with CKD. J Am Soc Nephrol. 2013 Jan;24(1):88–99.
   PubMed Web of Science ®Google Scholar
• Ito S, Yoshida M. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients. Toxins (Basel). 2014 Feb 20;6(2):665–678.
   PubMed Web of Science ®Google Scholar
• Cupisti A, Piccoli GB, Gallieni M. Charcoal for the management of pruritus and uremic toxins in patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2020 Jan;29(1):71–79.
   PubMed Web of Science ®Google Scholar
• Wu IW, Hsu KH, Hsu HJ, et al. Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients–a prospective cohort study. Nephrol Dial Transplant. 2012 Mar;27(3):1169–1175.
   PubMed Web of Science ®Google Scholar
• Barreto FC, Barreto DV, Liabeuf S, et al. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol. 2009 Oct;4(10):1551–1558.
   PubMed Web of Science ®Google Scholar
• Meijers BK, De Loor H, Bammens B, et al. p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients. Clin J Am Soc Nephrol. 2009 Dec;4(12):1932–1938.
   PubMed Web of Science ®Google Scholar
• Lin CN, Wu IW, Huang YF, et al. Measuring serum total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease using UPLC-MS/MS. J Food Drug Anal. 2019 Apr;27(2):502–509.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Fouque D, Heimburger O, et al. Nutritional status in dialysis patients: a European consensus. Nephrol Dial Transplant. 2002 Apr;17(4):563–572.
   PubMed Web of Science ®Google Scholar
• Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, national kidney foundation. Am J Kidney Dis. 2000 Jun;35(6Suppl 2):S1–140.
   PubMedGoogle Scholar
• van de Logt AE, Rijpma SR, Vink CH, et al. The bias between different albumin assays may affect clinical decision-making. Kidney Int. 2019 Jun;95(6):1514–1517.
   PubMed Web of Science ®Google Scholar
• Friedman AN, Fadem SZ. Reassessment of albumin as a nutritional marker in kidney disease. J Am Soc Nephrol. 2010 Feb;21(2):223–230.
   PubMed Web of Science ®Google Scholar
• De Mutsert R, Grootendorst DC, Indemans F, et al. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr. 2009 Mar;19(2):127–135.
   PubMed Web of Science ®Google Scholar
• Kaysen GA, Dubin JA, Muller HG, et al. Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. Kidney Int. 2004 Apr;65(4):1408–1415.
   PubMed Web of Science ®Google Scholar
• Kopple JD. McCollum Award Lecture, 1996: protein-energy malnutrition in maintenance dialysis patients. Am J Clin Nutr. 1997 May;65(5):1544–1557.
   PubMed Web of Science ®Google Scholar
• Mehrotra R, Kopple JD. Nutritional management of maintenance dialysis patients: why aren’t we doing better? Annu Rev Nutr. 2001;21:343–379.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Ikizler TA, Block G, et al. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003 Nov;42(5):864–881.
   PubMed Web of Science ®Google Scholar
• Oliveira EA, Zheng R, Carter CE, et al. Cachexia/Protein energy wasting syndrome in CKD: causation and treatment. Semin Dial. 2019 Nov;32(6):493–499.
   PubMed Web of Science ®Google Scholar
• Piccoli G, Bonello F, Massara C, et al. Death in conditions of cachexia: the price for the dialysis treatment of the elderly? Kidney Int Suppl. 1993;41:S282–6.
   PubMedGoogle Scholar
• Obi Y, Qader H, Kovesdy CP, et al. Latest consensus and update on protein-energy wasting in chronic kidney disease. Curr Opin Clin Nutr Metab Care. 2015 May;18(3):254–262.
   PubMed Web of Science ®Google Scholar
• Beddhu S, Pappas LM, Ramkumar N, et al. Malnutrition and atherosclerosis in dialysis patients. J Am Soc Nephrol. 2004 Mar;15(3):733–742.
   PubMed Web of Science ®Google Scholar
• Pecoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition, inflammation, and atherosclerosis (MIA) syndrome – the heart of the matter. Nephrol Dial Transplant. 2002;17(Suppl 11):28–31.
   PubMed Web of Science ®Google Scholar
• Maraj M, Kuśnierz-Cabala B, Dumnicka P, et al. Malnutrition, Inflammation, Atherosclerosis Syndrome (MIA) and diet recommendations among end-stage renal disease patients treated with maintenance hemodialysis. Nutrients. 2018;10(1):69.
   PubMed Web of Science ®Google Scholar
• Koppe L, Fouque D, Kalantar-Zadeh K. Kidney cachexia or protein-energy wasting in chronic kidney disease: facts and numbers. J Cachexia Sarcopenia Muscle. 2019 Jun;10(3):479–484.
   PubMed Web of Science ®Google Scholar
• Carrero JJ, Stenvinkel P, Cuppari L, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr. 2013 Mar;23(2):77–90.
   PubMed Web of Science ®Google Scholar
• Anton-Perez G, Santana-Del-Pino A, Henriquez-Palop F, et al. Diagnostic usefulness of the protein energy wasting score in prevalent hemodialysis patients. J Ren Nutr. 2018 Nov;28(6):428–434.
   PubMed Web of Science ®Google Scholar
• Santoro A, Mancini E. Hemodialysis and the elderly patient: complications and concerns. J Nephrol. 2010 Sep-Oct;23(Suppl 15):S80–9.
   PubMedGoogle Scholar
• Abdulan IM, Onofriescu M, Stefaniu R, et al. The predictive value of malnutrition for functional and cognitive status in elderly hemodialysis patients. Int Urol Nephrol. 2019 Jan;51(1):155–162.
   PubMed Web of Science ®Google Scholar
• Piccoli GB, Mezza E, Anania P, et al. Patients on renal replacement therapy for 20 or more years: a clinical profile. Nephrol Dial Transplant. 2002 Aug;17(8):1440–1449.
   PubMed Web of Science ®Google Scholar
• Omari AM, Omari LS, Dagash HH, et al. Assessment of nutritional status in the maintenance of haemodialysis patients: a cross-sectional study from Palestine. BMC Nephrol. 2019 Mar 15;20(1):92.
   PubMedGoogle Scholar
• Kittiskulnam P, Chertow GM, Carrero JJ, et al. Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis. Kidney Int. 2017 Jul;92(1):238–247.
   PubMed Web of Science ®Google Scholar
• Malhotra R, Deger SM, Salat H, et al. Sarcopenic obesity definitions by body composition and mortality in the hemodialysis patients. J Ren Nutr. 2017 Mar;27(2):84–90.
   PubMed Web of Science ®Google Scholar
• Kittiskulnam P, Carrero JJ, Chertow GM, et al. Sarcopenia among patients receiving hemodialysis: weighing the evidence. J Cachexia Sarcopenia Muscle. 2017;8(1):57–68.
   PubMed Web of Science ®Google Scholar
• Sabatino A, Cuppari L, and Stenvinkel P, et al. Sarcopenia in chronic kidney disease: what have we learned so far? J Nephrol. 2021 34;1347–1372 Sep 2.
   Google Scholar
• Riella MC. Nutritional evaluation of patients receiving dialysis for the management of protein-energy wasting: what is old and what is new? J Ren Nutr. 2013 May;23(3):195–198.
   PubMed Web of Science ®Google Scholar
• Rodrigues J, Santin F, Brito F, et al. Nutritional status of older patients on hemodialysis: which nutritional markers can best predict clinical outcomes? Nutrition. 2019 Sep;65:113–119.
   PubMed Web of Science ®Google Scholar
• Chumlea WC, Dwyer J, Bergen C, et al. Nutritional status assessed from anthropometric measures in the HEMO study. J Ren Nutr. 2003 Jan;13(1):31–38.
   PubMed Web of Science ®Google Scholar
• Enia G, Sicuso C, Alati G, et al. Subjective global assessment of nutrition in dialysis patients. Nephrol Dialysis Transplantation. 1993;8(10):1094–1098.
   PubMed Web of Science ®Google Scholar
• Piccoli GB, Lippi F, Fois A, et al. Intradialytic nutrition and hemodialysis prescriptions: a personalized stepwise approach. Nutrients. 2020;12(3):785.
   PubMed Web of Science ®Google Scholar
• Eriguchi R, Obi Y, Streja E, et al. Longitudinal associations among renal urea clearance–corrected normalized protein catabolic rate, serum albumin, and mortality in patients on hemodialysis. Clin J Am Soc Nephrol. 2017;12(7):1109–1117.
   PubMed Web of Science ®Google Scholar
• Susantitaphong P, Siribamrungwong M, Jaber BL. Convective therapies versus low-flux hemodialysis for chronic kidney failure: a meta-analysis of randomized controlled trials. Nephrol Dialysis Transplantation. 2013;28(11):2859–2874.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Ficociello LH, Bazzanella J, et al. Slipping through the pores: hypoalbuminemia and albumin loss during hemodialysis. Int J Nephrol Renovasc Dis. 2021;14:11–21.
   PubMed Web of Science ®Google Scholar
• Tsuchida K, Minakuchi J. Albumin loss under the use of the high-performance membrane. Contrib Nephrol. 2011;173:76–83.
   PubMed Web of Science ®Google Scholar
• Krieter DH, Canaud B. High permeability of dialysis membranes: what is the limit of albumin loss? Nephrol Dial Transplant. 2003 Apr;18(4):651–654.
   PubMed Web of Science ®Google Scholar
• Canaud B, Bragg-Gresham JL, Marshall MR, et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int. 2006 Jun;69(11):2087–2093.
   PubMed Web of Science ®Google Scholar
• Tomisawa N, Yamashita AC. Amount of adsorbed albumin loss by dialysis membranes with protein adsorption. J Artif Organs. 2009;12(3):194–199.
   PubMed Web of Science ®Google Scholar
• Ronco C, Marchionna N, Brendolan A, et al. Expanded haemodialysis: from operational mechanism to clinical results. Nephrol Dialysis Transplantation. 2018;33(suppl_3):iii41–iii47.
   PubMedGoogle Scholar
• van Gelder MK, Abrahams AC, Joles JA, et al. Albumin handling in different hemodialysis modalities. Nephrol Dial Transplant. 2018 Jun 1;33(6):906–913.
   PubMed Web of Science ®Google Scholar
• Hutchison CA, Harding S, Mead G, et al. Serum free-light chain removal by high cutoff hemodialysis: optimizing removal and supportive care. Artif Organs. 2008 Dec;32(12):910–917.
   PubMed Web of Science ®Google Scholar
• Cho NJ, Park S, Islam MI, et al. Long-term effect of medium cut-off dialyzer on middle uremic toxins and cell-free hemoglobin. PLoS One. 2019;14(7):e0220448.
   PubMed Web of Science ®Google Scholar
• Boschetti-de-Fierro A, Voigt M, Storr M, et al. MCO membranes: enhanced selectivity in high-flux class. Sci Rep. 2015 Dec;16(5):18448.
   Google Scholar
• Belmouaz M, Diolez J, Bauwens M, et al. Comparison of hemodialysis with medium cut-off dialyzer and on-line hemodiafiltration on the removal of small and middle-sized molecules. Clin Nephrol. 2018 Jan;89(1):50–56.
   PubMed Web of Science ®Google Scholar
• Mercadal L, Franck JE, Metzger M, et al. Hemodiafiltration versus hemodialysis and survival in patients with ESRD: the French Renal Epidemiology and Information Network (REIN) registry. Am J Kidney Dis. 2016 Aug;68(2):247–255.
   PubMed Web of Science ®Google Scholar
• Peters SA, Bots ML, Canaud B, et al. Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials. Nephrol Dial Transplant. 2016 Jun;31(6):978–984.
   PubMed Web of Science ®Google Scholar
• Nistor I, Palmer SC, Craig JC, et al. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease. Cochrane Database Syst Rev. 2015 May;20(5):Cd006258.
   Google Scholar
• Vega A, Quiroga B, Abad S, et al. Albumin leakage in online hemodiafiltration, more convective transport, more losses? Ther Apher Dial. 2015 Jun;19(3):267–271.
   PubMed Web of Science ®Google Scholar
• Ok E, Asci G, Toz H, et al. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dialysis Transplantation. 2012;28(1):192–202.
   PubMed Web of Science ®Google Scholar
• Morena M, Jaussent A, Chalabi L, et al. Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly. Kidney Int. 2017;91(6):1495–1509.
   PubMed Web of Science ®Google Scholar
• Piccoli GB, Cabiddu G, Moio MR, et al. Efficiency and nutritional parameters in an elderly high risk population on hemodialysis and hemodiafiltration in Italy and France: different treatments with similar names? BMC Nephrol. 2018 Jul 9;19(1):171.
   PubMedGoogle Scholar
• Tsuchida K, Minakuchi J. Effect of large-size dialysis membrane and hemofiltration/hemodiafiltration methods on long-term dialysis patients. Contrib Nephrol. 2011;168:179–187.
   PubMed Web of Science ®Google Scholar
• Hoshino J, Yamagata K, Nishi S, et al. Significance of the decreased risk of dialysis-related amyloidosis now proven by results from Japanese nationwide surveys in 1998 and 2010. Nephrol Dial Transplant. 2016 Apr;31(4):595–602.
   PubMed Web of Science ®Google Scholar
• Masakane I. How to prescribe hemodialysis or hemodiafiltration in order to ameliorate dialysis-related symptoms and complications. Contrib Nephrol. 2011;168:53–63.
   PubMed Web of Science ®Google Scholar
• Schiffl H. Online hemodiafiltration and mortality risk in end-stage renal disease patients: a critical appraisal of current evidence. Kidney Res Clin Pract. 2019;38(2):159–168.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Karaboyas A, Pisoni RL, et al. Mortality risk in patients on hemodiafiltration versus hemodialysis: a ‘real-world’ comparison from the DOPPS. Nephrol Dialysis Trans. 2018;33(4):683–689.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Carfagna F, Del Vecchio L, et al. Haemodialysis or haemodiafiltration: that is the question. Nephrol Dial Transplant. 2018 Nov 1;33(11):1896–1904.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Di Filippo S, Pontoriero G. Fluid and electrolyte balance during extracorporeal therapies. In: Ronco C, Bellomo R, editors. Critical care nephrology. Dordrecht: Springer Netherlands; 1998. p. 249–259.
   Google Scholar
• Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998 Apr;31(4):607–617.
   PubMed Web of Science ®Google Scholar
• Young EW, Albert JM, Satayathum S, et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2005 Mar;67(3):1179–1187.
   PubMed Web of Science ®Google Scholar
• Cozzolino M, Ciceri P, Galassi A, et al. The key role of phosphate on vascular calcification. Toxins (Basel). 2019;11(4):213.
   PubMed Web of Science ®Google Scholar
• Tentori F, Blayney MJ, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2008 Sep;52(3):519–530.
   PubMed Web of Science ®Google Scholar
• Bover J, Urena P, Brandenburg V, et al. Adynamic bone disease: from bone to vessels in chronic kidney disease. Semin Nephrol. 2014 Nov;34(6):626–640.
   PubMed Web of Science ®Google Scholar
• Messa P, Alfieri CM. Secondary and tertiary hyperparathyroidism. Front Horm Res. 2019;51:91–108.
   PubMed Web of Science ®Google Scholar
• Vilar E, Fry AC, Wellsted D, et al. Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis. Clin J Am Soc Nephrol. 2009;4(12):1944–1953.
   PubMed Web of Science ®Google Scholar
• Daugirdas JT, Chertow GM, Larive B, et al. Effects of frequent hemodialysis on measures of CKD mineral and bone disorder. J Am Soc Nephrol. 2012 Apr;23(4):727–738.
   PubMed Web of Science ®Google Scholar
• D’Alessandro C, Piccoli GB, Cupisti A. The “phosphorus pyramid”: a visual tool for dietary phosphate management in dialysis and CKD patients. BMC Nephrol. 2015 Jan;20(16):9.
   Google Scholar
• Ruospo M, Palmer SC, Natale P, et al. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD). Cochrane Database Syst Rev. 2018 Aug 22;8(8):Cd006023.
   PubMedGoogle Scholar
• Barreto FC, Barreto DV, Massy ZA, et al. Strategies for phosphate control in patients with CKD. Kidney Int Rep. 2019;4(8):1043–1056.
   PubMed Web of Science ®Google Scholar
• Shen J, Li W, Wang Y, et al. Higher serum phosphorus predicts residual renal function loss in male but not female incident peritoneal dialysis patients. J Nephrol. 2020 Aug;33(4):829–837.
   PubMed Web of Science ®Google Scholar
• Zoccali C, Moissl U, Chazot C, et al. Chronic fluid overload and mortality in ESRD. J Am Soc Nephrol. 2017 Aug;28(8):2491–2497.
   PubMed Web of Science ®Google Scholar
• Beerendrakumar N, Ramamoorthy L, Haridasan S. Dietary and fluid regime adherence in chronic kidney disease patients. J Caring Sci. 2018;7(1):17–20.
   PubMedGoogle Scholar
• Ozen N, Cinar FI, Askin D, et al. Nonadherence in hemodialysis patients and related factors: a multicenter study. J Nurs Res. 2019;27(4):e36.
   PubMedGoogle Scholar
• Assimon MM, Wenger JB, Wang L, et al. Ultrafiltration rate and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2016;68(6):911–922.
   PubMed Web of Science ®Google Scholar
• Kim TW, Chang TI, Kim TH, et al. Association of ultrafiltration rate with mortality in incident hemodialysis patients. Nephron. 2018;139(1):13–22.
   PubMed Web of Science ®Google Scholar
• Chou JA, Streja E, Nguyen DV, et al. Intradialytic hypotension, blood pressure changes and mortality risk in incident hemodialysis patients. Nephrol Dial Transplant. 2018 Jan 1;33(1):149–159.
   PubMed Web of Science ®Google Scholar
• Yu J, Liu Z, Shen B, et al. Intradialytic hypotension as an independent risk factor for long-term mortality in maintaining hemodialysis patients: a 5-Year follow-up cohort study. Blood Purif. 2018;45(4):320–326.
   PubMed Web of Science ®Google Scholar
• Sars B, van der Sande FM, Kooman JP. Intradialytic hypotension: mechanisms and outcome. Blood Purif. 2020;49(1–2):158–167.
   PubMedGoogle Scholar
• Chang TI, Paik J, Greene T, et al. Intradialytic hypotension and vascular access thrombosis. J Am Soc Nephrol. 2011 Aug;22(8):1526–1533.
   PubMed Web of Science ®Google Scholar
• Burton JO, Jefferies HJ, Selby NM, et al. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol. 2009;4(5):914–920.
   PubMed Web of Science ®Google Scholar
• Davenport A, Cox C, Thuraisingham R. Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension. Kidney Int. 2008;73(6):759–764.
   PubMed Web of Science ®Google Scholar
• Rocha A, Sousa C, Teles P, et al. Effect of dialysis day on intradialytic hypotension risk. Kidney Blood Press Res. 2016;41(2):168–174.
   PubMed Web of Science ®Google Scholar
• Kuipers J, Oosterhuis JK, Paans W, et al. Association between quality of life and various aspects of intradialytic hypotension including patient-reported intradialytic symptom score. BMC Nephrol. 2019 May 14;20(1):164.
   PubMedGoogle Scholar
• Jansen MA, Hart AA, Korevaar JC, et al. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002 Sep;62(3):1046–1053.
   PubMed Web of Science ®Google Scholar
• Santoro A, Mancini E, Basile C, et al. Blood volume controlled hemodialysis in hypotension-prone patients: a randomized, multicenter controlled trial. Kidney Int. 2002 Sep;62(3):1034–1045.
   PubMed Web of Science ®Google Scholar
• MacEwen C, Sutherland S, Daly J, et al. Relationship between Hypotension and Cerebral Ischemia during Hemodialysis. J Am Soc Nephrol. 2017 Aug;28(8):2511–2520.
   PubMed Web of Science ®Google Scholar
• van der Sande FM, Cheriex EC, van Kuijk WH, et al. Effect of dialysate calcium concentrations on intradialytic blood pressure course in cardiac-compromised patients. Am J Kidney Dis. 1998 Jul;32(1):125–131.
   PubMed Web of Science ®Google Scholar
• Penne EL, Sergeyeva O. Sodium gradient: a tool to individualize dialysate sodium prescription in chronic hemodialysis patients? Blood Purif. 2011;31(1–3):86–91.
   PubMed Web of Science ®Google Scholar
• Keen ML, Gotch FA. The association of the sodium “setpoint” to interdialytic weight gain and blood pressure in hemodialysis patients. Int J Artif Organs. 2007 Nov;30(11):971–979.
   PubMed Web of Science ®Google Scholar
• Kotanko P, Garg AX, Depner T, et al. Effects of frequent hemodialysis on blood pressure: results from the randomized frequent hemodialysis network trials. Hemodial Int. 2015 Jul;19(3):386–401.
   PubMed Web of Science ®Google Scholar
• Leung KC, Quinn RR, Ravani P, et al. Ultrafiltration biofeedback guided by blood volume monitoring to reduce intradialytic hypotensive episodes in hemodialysis: study protocol for a randomized controlled trial. Trials. 2014 Dec;10(15):483.
   Google Scholar
• Reddan DN, Szczech LA, Hasselblad V, et al. Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial. J Am Soc Nephrol. 2005 Jul;16(7):2162–2169.
   PubMed Web of Science ®Google Scholar
• Hur E, Usta M, Toz H, et al. Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial. Am J Kidney Dis. 2013 Jun;61(6):957–965.
   PubMed Web of Science ®Google Scholar
• Kanbay M, Ertuglu LA, Afsar B, et al. An update review of intradialytic hypotension: concept, risk factors, clinical implications and management. Clin Kidney J. 2020;13(6):981–993.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Altieri P, Andrulli S, et al. Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. J Am Soc Nephrol. 2010;21(10):1798–1807.
   PubMed Web of Science ®Google Scholar
• Tessitore N, Santoro A, Panzetta GO, et al. Acetate-free biofiltration reduces intradialytic hypotension: a European multicenter randomized controlled trial. Blood Purif. 2012;34(3–4):354–363.
   PubMed Web of Science ®Google Scholar
• Petrović DG. Influence of acetate-free biofiltration on intradialytic cardiovascular stability. Dialysis Trans. 2006;35(6):376–384.
   Google Scholar
• Adamczak M, Masajtis-Zagajewska A, Mazanowska O, et al. Diagnosis and treatment of metabolic acidosis in patients with chronic kidney disease - position statement of the working group of the polish society of nephrology. Kidney Blood Press Res. 2018;43(3):959–969.
   PubMed Web of Science ®Google Scholar
• Wu DY, Shinaberger CS, Regidor DL, et al. Association between serum bicarbonate and death in hemodialysis patients: is it better to be acidotic or alkalotic? Clin J Am Soc Nephrol. 2006 Jan 1;1:70–78.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Shoji S, Yamakawa T, et al. Predialysis and Postdialysis pH and Bicarbonate and risk of all-cause and cardiovascular mortality in long-term hemodialysis patients. Am J Kidney Dis. 2015 Sep;66(3):469–478.
   PubMed Web of Science ®Google Scholar
• Murea M. Precision medicine approach to dialysis including incremental and decremental dialysis regimens. Curr Opin Nephrol Hypertens. 2021;30(1):85–92.
   PubMed Web of Science ®Google Scholar
• DePalma JR, Pecker EA, Maxwell MH. A new automatic coil dialyzer system for ‘daily’ dialysis. Hemodial Int. 2004 Jan 1;8(1):19–23.
   PubMedGoogle Scholar
• Bonomini V, Mioli V, Albertazzi A, et al. Daily-dialysis programme: indications and results. Proc Eur Dial Transplant Assoc. 1972;9:44–52.
   PubMedGoogle Scholar
• Kjellstrand CM, Brief A. History of daily hemodialysis. Home Hemodial Int (1997). 1998 Jan;2(1):8–11.
   PubMedGoogle Scholar
• Suri RS, Nesrallah GE, Mainra R, et al. Daily hemodialysis: a systematic review. Clin J Am Soc Nephrol. 2006 1; Jan(1): 33–42.
   Google Scholar
• Piccoli GB, Calderini M, Bechis F, et al. Daily dialysis Kt/V and flexible schedules: is it possible to control efficiency, when and how? Int J Artif Organs. 2001 Jun;24(6):347–356.
   PubMed Web of Science ®Google Scholar
• Buoncristiani U, Quintaliani G, Cozzari M, et al. Daily dialysis: long-term clinical metabolic results. Kidney Int Suppl. 1988 Mar;24:S137–40.
   PubMedGoogle Scholar
• Buoncristiani U, Fagugli RM, Pinciaroli MR, et al. Reversal of left-ventricular hypertrophy in uremic patients by treatment with daily hemodialysis (DHD). Contrib Nephrol. 1996;119:152–156.
   PubMedGoogle Scholar
• Fagugli RM, Reboldi G, Quintaliani G, et al. Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis. 2001 Aug;38(2):371–376.
   PubMed Web of Science ®Google Scholar
• Floridi A, Antolini F, Galli F, et al. Daily haemodialysis improves indices of protein glycation. Nephrol Dial Transplant. 2002 May;17(5):871–878.
   PubMed Web of Science ®Google Scholar
• Buoncristiani U, Fagugli R, Quintaliani G, et al. Rationale for daily dialysis. Home Hemodial Int (1997). 1997 1; Jan(1): 12–18.
   Google Scholar
• Culleton BF, Walsh M, Klarenbach SW, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA. 2007 Sep 19;298(11):1291–1299.
   PubMed Web of Science ®Google Scholar
• Traeger J, Galland R, Delawari E, et al. Six years’ experience with short daily hemodialysis: do the early improvements persist in the mid and long term? Hemodial Int. 2004 Apr 1;8(2):151–158.
   PubMedGoogle Scholar
• Charra B, Terrat JC, Vanel T, et al. Long thrice weekly hemodialysis: the Tassin experience. Int J Artif Organs. 2004 Apr;27(4):265–283.
   PubMed Web of Science ®Google Scholar
• Daugirdas JT, Greene T, Rocco MV, et al. Effect of frequent hemodialysis on residual kidney function. Kidney Int. 2013 May;83(5):949–958.
   PubMed Web of Science ®Google Scholar
• Hladunewich MA, Hou S, Odutayo A, et al. Intensive hemodialysis associates with improved pregnancy outcomes: a Canadian and United States cohort comparison. J Am Soc Nephrol. 2014 May;25(5):1103–1109.
   PubMed Web of Science ®Google Scholar
• Barua M, Hladunewich M, Keunen J, et al. Successful pregnancies on nocturnal home hemodialysis. Clin J Am Soc Nephrol. 2008 3; Mar(2): 392–396.
   Google Scholar
• Cabiddu G, Castellino S, Gernone G, et al. Best practices on pregnancy on dialysis: the Italian study group on kidney and pregnancy. J Nephrol. 2015 Jun;28(3):279–288.
   PubMed Web of Science ®Google Scholar
• Caria S, Cupisti A, Sau G, et al. The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patients. BMC Nephrol. 2014 Oct;29(15):172.
   Google Scholar
• Bolasco P, Cupisti A, Locatelli F, et al. Dietary management of incremental transition to dialysis therapy: once-weekly hemodialysis combined with low-protein diet. J Ren Nutr. 2016 Nov;26(6):352–359.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Casino FG. Let us give twice-weekly hemodialysis a chance: revisiting the taboo. Nephrol Dial Transplant. 2014 Sep;29(9):1618–1620.
   PubMed Web of Science ®Google Scholar
• Libetta C, Esposito P, Dal Canton A. Once-weekly hemodialysis: a single-center experience. Am J Kidney Dis. 2015 Feb;65(2):343.
   PubMed Web of Science ®Google Scholar
• Kabanda A, Jadoul M, Pochet JM, et al. Determinants of the serum concentrations of low molecular weight proteins in patients on maintenance hemodialysis. Kidney Int. 1994 Jun;45(6):1689–1696.
   PubMed Web of Science ®Google Scholar
• Marquez IO, Tambra S, Luo FY, et al. Contribution of residual function to removal of protein-bound solutes in hemodialysis. Clin J Am Soc Nephrol. 2011 Feb;6(2):290–296.
   PubMed Web of Science ®Google Scholar
• Delaney MP, Stevens PE, Al Hasani M, et al. Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study. Am J Kidney Dis. 2008 Feb;51(2):278–284.
   PubMed Web of Science ®Google Scholar
• Van Der Wal WM, Noordzij M, Dekker FW, et al. Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model. Nephrol Dial Transplant. 2011 Sep;26(9):2978–2983.
   PubMed Web of Science ®Google Scholar
• Penne EL, van der Weerd NC, Grooteman MP, et al. Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients. Clin J Am Soc Nephrol. 2011 Feb;6(2):281–289.
   PubMed Web of Science ®Google Scholar
• Wang AY, Sea MM, Ip R, et al. Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol. 2001 Nov;12(11):2450–2457.
   PubMed Web of Science ®Google Scholar
• Menon MK, Naimark DM, Bargman JM, et al. Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant. 2001 Nov;16(11):2207–2213.
   PubMed Web of Science ®Google Scholar
• Tattersall J. Hemodialysis time and kt/v: less may be better. Semin Dial. 2017 Jan;30(1):10–14.
   PubMed Web of Science ®Google Scholar
• Garofalo C, Borrelli S, De Stefano T, et al. Incremental dialysis in ESRD: systematic review and meta-analysis. J Nephrol. 2019 Oct;32(5):823–836.
   PubMed Web of Science ®Google Scholar
• Gedney N, Kalantar-Zadeh K. Dialysis patient-centeredness and precision medicine: focus on incremental home hemodialysis and preserving residual kidney function. Semin Nephrol. 2018 Jul;38(4):426–432.
   PubMed Web of Science ®Google Scholar
• Murea M, Moossavi S, Garneata L, et al. Narrative review of incremental hemodialysis. Kidney Int Rep. 2020 Feb;5(2):135–148.
   PubMed Web of Science ®Google Scholar
• Daugirdas JT, Depner TA, Inrig J, et al. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Diseases. 2015 November 01 66(5):884–930.
   PubMed Web of Science ®Google Scholar
• Vilar E, Wellsted D, Chandna SM, et al. Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose. Nephrol Dial Transplant. 2009 Aug;24(8):2502–2510.
   PubMed Web of Science ®Google Scholar
• Penne EL, van der Weerd NC, Blankestijn PJ, et al. Role of residual kidney function and convective volume on change in beta2-microglobulin levels in hemodiafiltration patients. Clin J Am Soc Nephrol. 2010 Jan;5(1):80–86.
   PubMed Web of Science ®Google Scholar
• Oates T, Pinney JH, Davenport A. Haemodiafiltration versus high-flux haemodialysis: effects on phosphate control and erythropoietin response. Am J Nephrol. 2011;33(1):70–75.
   PubMed Web of Science ®Google Scholar
• Vilar E, Boltiador C, Viljoen A, et al. Removal and rebound kinetics of cystatin C in high-flux hemodialysis and hemodiafiltration. Clin J Am Soc Nephrol. 2014 Jul;9(7):1240–1247.
   PubMed Web of Science ®Google Scholar
• Casino FG, Basile C. The variable target model: a paradigm shift in the incremental haemodialysis prescription. Nephrol Dial Transplant. 2017 Jan 1; 32(1):182–190.
   PubMed Web of Science ®Google Scholar
• Garneata L, Stancu A, Dragomir D, et al. Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. J Am Soc Nephrol. 2016 Jul;27(7):2164–2176.
   PubMed Web of Science ®Google Scholar
• Garneata L, Mocanu CA, Mocanu AE, et al. Fo012vegetarian severe hypoproteic diet supplemented with keto-analogues for predialysis chronic kidney disease patients: the influence on long term prognosis. Nephrol Dialysis Transplantation. 2019;34(Supplement_1). https://doi.org/10.1093/ndt/gfz096.FO012.
   Google Scholar
• Depner TA, Daugirdas JT. Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics. J Am Soc Nephrol. 1996 May;7(5):780–785.
   PubMed Web of Science ®Google Scholar
• Casino FG, Mostacci SD, and Sabato A, et al. The lacking equation that estimates the protein catabolic rate in patients on once-weekly haemodialysis. J Nephrol. 2020. 34:459–464.
   Web of Science ®Google Scholar
• Schiffl H. High-volume online haemodiafiltration treatment and outcome of end-stage renal disease patients: more than one mode. Int Urol Nephrol. 2020 Aug;52(8):1501–1506.
   PubMed Web of Science ®Google Scholar
• Kikuchi K, Hamano T, Wada A, et al. Predilution online hemodiafiltration is associated with improved survival compared with hemodialysis. Kidney Int. 2019 Apr;95(4):929–938.
   PubMed Web of Science ®Google Scholar
• Masakane I, Kikuchi K, Kawanishi H. Evidence for the clinical advantages of predilution on-line hemodiafiltration. Contrib Nephrol. 2017;189:17–23.
   PubMed Web of Science ®Google Scholar